The Shift to Capacity Control
Market Signal – July 10, 2026 Imaging AI must increasingly prove that it can be paid, distributed or converted into operating capacity.
Reporting AI: The New Control Layer for Medical Imaging
Market Signal – June 12, 2026 The center of gravity in imaging AI is fundamentally shifting. In our analysis, the market has moved definitively past standalone detection algorithms and is now ruthlessly prioritizing operating infrastructure embedded directly into the radiologist’s daily workflow. This infographic captures the most aggressive commercial pivot we are tracking this week: […]
Imaging AI Market Signal – The Shift to Platform Control
Market Signal – June 5, 2026 The medical imaging market has exited the era of standalone AI features and is aggressively repricing around platform control. Healthcare systems are no longer simply buying diagnostic algorithms; they are buying operating infrastructure designed to directly attack their severe labor and capacity constraints. What the visual is telling us: […]
Sectra Completes Oxipit Acquisition (2026-04-15)
Sectra / Oxipit — Market Signals | Marketstrat Marketstrat|Market Signals Deal Intelligence · MedTech Event-Driven Analysis No. 02 · April 2026 M&A · Radiology AI · EU → EU Sectra pulls autonomous AI inside the enterprise imaging stack. Completion of the Oxipit acquisition consolidates the independent autonomous chest X-ray AI market into two platforms in […]
Neuropacs De Novo: First FDA-Authorized AI Pathway for Chronic Neurodegenerative Disease Differentiation
Event Date: April 3, 2026 (FDA decision) | April 7, 2026 (public announcement) Marketstrat® · Markintel Market Signals Neuropacs De Novo: First FDA-Authorized AI Pathway for Chronic Neurodegenerative Disease Differentiation Published: April 16, 2026 Sector: MedTech & Digital Health Focus: Neurological Imaging AI FDA grants De Novo classification to neuropacs™ (April 3, 2026) Creates a […]
The Highest-Value AI Frontier Is Shifting from Interpretation to Acquisition
Innovation Hook · Butterfly Network (NYSE: BFLY) The Highest-Value AI Frontier Is Shifting from Interpretation to Acquisition FDA clearance of first blind-sweep gestational age tool · March 30, 2026 Most radiology AI analyzes images after a skilled operator captures them. Butterfly’s GA Tool automates the scan itself — eliminating the operator skill requirement entirely. That […]
RadNet Acquires Gleamer: The Radiology AI Platform Consolidation Thesis Takes Shape
This is an excerpt of Marketstrat’s full strategic analysis. The complete research note — including detailed competitive landscape analysis, integration risk assessment, and company profiles — is available to clients. EXECUTIVE SUMMARY On March 2, 2026, RadNet, Inc. (NASDAQ: RDNT) completed its acquisition of Gleamer SAS, a Paris-based radiology AI company, for up to €230 […]
GE HealthCare: Procedure-Room AI Platformization Accelerates
Date: February 11, 2026 | Company: GE Healthcare (GEHC) | Sector Lens: Interventional Imaging + Workflow AI | Cath Lab Economics | Platform Procurement GE HealthCare’s Allia Moveo FDA clearance/CE Mark is a signal that AI is embedding directly into interventional imaging workflows. The same-week Medtronic–CathWorks deal highlights a parallel consolidation of angiography-derived decision support, […]
ScreenPoint Medical: MASAI makes breast AI procurement-grade screening infrastructure
Date: February 5, 2026 | Sector Lens: Medical Imaging + AI (Breast screening / mammography workflow) ScreenPoint Medical’s Transpara-enabled MASAI randomized trial published its primary endpoint in The Lancet, showing a non-inferior interval cancer rate versus standard double reading with higher sensitivity and unchanged specificity. We interpret this as a market signal that breast AI […]
Siemens Healthineers: MRI’s next battleground is “constraint removal,” not “image quality.”
Date: February 4, 2026 | Sector Lens: MRI + Embedded AI | Provider ops | Sustainability/TCO | Siting & infrastructure Siemens’ FDA-cleared 70cm MAGNETOM Flow platform signals an MRI procurement shift toward constraint removal—helium exposure, siting friction, and energy intensity—supported by embedded workflow and reconstruction AI. The strategic question for providers is not “better images,” […]
